XRTX Projected Dividend Yield
XORTX Therapeutics Inc ( NASDAQ : XRTX )XORTX Therapeutics is a late clinical-stage biotechnology company focused on identifying, developing and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan (rate) disease indications. Co.'s three primary product candidates are: XRx-008, a program for the treatment of autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury associated with severe virus infection and associated health consequences; and XRx-225, a program for the treatment of type 2 diabetic nephropathy. 20 YEAR PERFORMANCE RESULTS |
XRTX Dividend History Detail XRTX Dividend News XRTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |